These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17192548)

  • 1. Enoxaparin in elective percutaneous coronary intervention.
    Bhala N
    N Engl J Med; 2006 Dec; 355(26):2788; author reply 2790-1. PubMed ID: 17192548
    [No Abstract]   [Full Text] [Related]  

  • 2. Enoxaparin in elective percutaneous coronary intervention.
    Hamon M; Riddell JW
    N Engl J Med; 2006 Dec; 355(26):2788-9; author reply 2790-1. PubMed ID: 17195309
    [No Abstract]   [Full Text] [Related]  

  • 3. Enoxaparin in elective percutaneous coronary intervention.
    Schuler J; Altenberger J; Heigert M
    N Engl J Med; 2006 Dec; 355(26):2789-90; author reply 2790-1. PubMed ID: 17193723
    [No Abstract]   [Full Text] [Related]  

  • 4. Enoxaparin in elective percutaneous coronary intervention.
    Pasceri V
    N Engl J Med; 2006 Dec; 355(26):2789; author reply 2790-1. PubMed ID: 17195306
    [No Abstract]   [Full Text] [Related]  

  • 5. Enoxaparin in elective percutaneous coronary intervention.
    Karthikeyan G
    N Engl J Med; 2006 Dec; 355(26):2789; author reply 2790-1. PubMed ID: 17195310
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of bleeding after elective percutaneous coronary intervention.
    O'Neill WW
    N Engl J Med; 2006 Sep; 355(10):1058-60. PubMed ID: 16957154
    [No Abstract]   [Full Text] [Related]  

  • 7. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.
    Montalescot G; White HD; Gallo R; Cohen M; Steg PG; Aylward PE; Bode C; Chiariello M; King SB; Harrington RA; Desmet WJ; Macaya C; Steinhubl SR;
    N Engl J Med; 2006 Sep; 355(10):1006-17. PubMed ID: 16957147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical issues on the use of enoxaparin in elective and emergent percutaneous coronary intervention.
    Díez JG
    J Invasive Cardiol; 2008 Sep; 20(9):482-9. PubMed ID: 18762681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
    White HD; Kleiman NS; Mahaffey KW; Lokhnygina Y; Pieper KS; Chiswell K; Cohen M; Harrington RA; Chew DP; Petersen JL; Berdan LG; Aylward PE; Nessel CC; Ferguson JJ; Califf RM
    Am Heart J; 2006 Dec; 152(6):1042-50. PubMed ID: 17161049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction.
    Zeymer U; Gitt A; Jünger C; Bauer T; Heer T; Koeth O; Wienbergen H; Zahn R; Senges J
    Thromb Haemost; 2008 Jan; 99(1):150-4. PubMed ID: 18217147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enoxaparin versus unfractionated heparin in ST-elevation myocardial infarction.
    Sleight P; Eikelboom JW; Bassand JP
    N Engl J Med; 2006 Jun; 354(26):2830-1; author reply 2831-2. PubMed ID: 16810777
    [No Abstract]   [Full Text] [Related]  

  • 12. Exploring the role of enoxaparin in the management of high-risk patients with non-ST-elevation acute coronary syndromes: the SYNERGY trial.
    Mahaffey KW; Ferguson JJ
    Am Heart J; 2005 Apr; 149(4 Suppl):S81-90. PubMed ID: 16124952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unfractionated versus low-molecular-weight heparin for primary angioplasty-More data suggesting to go low.
    Moliterno DJ
    Catheter Cardiovasc Interv; 2011 Feb; 77(2):191-2. PubMed ID: 21290553
    [No Abstract]   [Full Text] [Related]  

  • 14. Subcutaneous enoxaparin with early invasive strategy in patients with acute coronary syndromes.
    Collet JP; Montalescot G; Golmard JL; Tanguy ML; Ankri A; Choussat R; Beygui F; Drobinski G; Vignolles N; Thomas D
    Am Heart J; 2004 Apr; 147(4):655-61. PubMed ID: 15077081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enoxaparin experience in percutaneous coronary intervention.
    Somani V; Trivedi S
    J Indian Med Assoc; 2008 Jan; 106(1):12-5. PubMed ID: 18705262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of fondaparinux and enoxaparin in acute coronary syndromes.
    ; Yusuf S; Mehta SR; Chrolavicius S; Afzal R; Pogue J; Granger CB; Budaj A; Peters RJ; Bassand JP; Wallentin L; Joyner C; Fox KA
    N Engl J Med; 2006 Apr; 354(14):1464-76. PubMed ID: 16537663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease.
    Chen JL; Chen J; Qiao SB; Guo YL; Wu YJ; Dai J; Yuan JQ; Qin XW; Yang YJ; Gao RL
    Chin Med J (Engl); 2006 Mar; 119(5):355-9. PubMed ID: 16542576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of anticoagulation regimens on sheath management and bleeding in patients undergoing elective percutaneous coronary intervention in the STEEPLE trial.
    Gallo R; Steinhubl SR; White HD; Montalescot G;
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):319-25. PubMed ID: 19213086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin.
    Montalescot G; Collet JP; Tanguy ML; Ankri A; Payot L; Dumaine R; Choussat R; Beygui F; Gallois V; Thomas D
    Circulation; 2004 Jul; 110(4):392-8. PubMed ID: 15249498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can enoxaparin safely replace unfractionated heparin during coronary intervention in acute coronary syndromes?
    Wolak A; Ayzenberg Y; Cafri C; Gilutz H; Ilia R; Zahger D
    Int J Cardiol; 2004 Aug; 96(2):151-5. PubMed ID: 15262028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.